Impact of Increased Use of Single-Inhaler Triple Therapies on COPD Exacerbation Rates, Mortality, and Total Costs: PROMETHEUS France.

Saved in:
Bibliographic Details
Title: Impact of Increased Use of Single-Inhaler Triple Therapies on COPD Exacerbation Rates, Mortality, and Total Costs: PROMETHEUS France.
Authors: Deslee G; Service de Pneumologie, INSERM UMRS-1250, Hospital Universitaire de Reims, Reims, France., Russo H; Astrazeneca, Medical Department, Courbevoie, France., Fabry-Vendrand C; Astrazeneca, Medical Department, Courbevoie, France., Koskas D; Astrazeneca, Medical Department, Courbevoie, France., Thabut G; Astrazeneca, Medical Department, Courbevoie, France., Bell JP; AstraZeneca, Global Respiratory & Immunology, BioPharmaceuticals Medical, Cambridge, UK., Caplen M; Milliman,New York, NY, USA., Bhatt PD; Milliman,New York, NY, USA., Carioto J; Milliman,New York, NY, USA., Pyenson B; Milliman,New York, NY, USA., Burgel PR; Service de Pneumologie, Hôpital Cochin, Assistance Publique Hôpitaux de Paris et Université Paris Cité, Institut Cochin, INSERM U1016, Paris, France.
Source: International journal of chronic obstructive pulmonary disease [Int J Chron Obstruct Pulmon Dis] 2025 Nov 17; Vol. 20, pp. 3753-3763. Date of Electronic Publication: 2025 Nov 17 (Print Publication: 2025).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: DOVE Medical Press Country of Publication: New Zealand NLM ID: 101273481 Publication Model: eCollection Cited Medium: Internet ISSN: 1178-2005 (Electronic) Linking ISSN: 11769106 NLM ISO Abbreviation: Int J Chron Obstruct Pulmon Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1178-2005
DOI:10.2147/COPD.S539055